4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) Given Consensus Recommendation of “Moderate Buy” by Brokerages
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the ten brokerages that are covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and eight have issued a buy recommendation on the […]
18 Jan 10:32 · The Cerbat Gem